Literature DB >> 1962098

Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates.

J C Ridderhof1, R J Wallace, J O Kilburn, W R Butler, N G Warren, M Tsukamura, L C Steele, E S Wong.   

Abstract

Six cases of chronic tenosynovitis of the hand due to the Mycobacterium terrae complex were identified. All isolates from the six cases were identified as Mycobacterium nonchromogenicum by high-performance liquid chromatography and by testing for susceptibility to ofloxacin and to 5% NaCl. Ethambutol, sulfonamides (or trimethoprim-sulfamethoxazole), erythromycin, and streptomycin are the drugs most active against isolates of the M. terrae complex, and therapy with some combination of these agents plus surgical debridement offers the best current treatment of this disease. This study supports the contention arising from previous case reports of pulmonary disease that M. nonchromogenicum is the pathogenic member of the M. terrae complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1962098     DOI: 10.1093/clinids/13.5.857

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Separation among species of Mycobacterium terrae complex by lipid analyses: comparison with biochemical tests and 16S rRNA sequencing.

Authors:  P Torkko; M Suutari; S Suomalainen; L Paulin; L Larsson; M L Katila
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Routine application of high-performance liquid chromatography for identification of mycobacteria.

Authors:  L Thibert; S Lapierre
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

4.  Mycobacterium arupense, Mycobacterium heraklionense, and a Newly Proposed Species, "Mycobacterium virginiense" sp. nov., but Not Mycobacterium nonchromogenicum, as Species of the Mycobacterium terrae Complex Causing Tenosynovitis and Osteomyelitis.

Authors:  Ravikiran Vasireddy; Sruthi Vasireddy; Barbara A Brown-Elliott; Nancy L Wengenack; Uzoamaka A Eke; Jeana L Benwill; Christine Turenne; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2016-03-09       Impact factor: 5.948

5.  Relatively alcohol-resistant mycobacteria are emerging pathogens in patients receiving acupuncture treatment.

Authors:  Patrick C Y Woo; Kit-Wah Leung; Samson S Y Wong; Ken T K Chong; Elim Y L Cheung; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography.

Authors:  W R Butler; L Thibert; J O Kilburn
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  Direct identification of Mycobacterium species in BACTEC 7H12B medium by high-performance liquid chromatography.

Authors:  G D Cage
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Curvilinear-gradient high-performance liquid chromatography for identification of mycobacteria.

Authors:  L S Guthertz; S D Lim; Y Jang; P S Duffey
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Strains of Mycobacterium terrae complex which react with DNA probes for M. tuberculosis complex.

Authors:  E G Ford; S J Snead; J Todd; N G Warren
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models.

Authors:  K C Jost; D F Dunbar; S S Barth; V L Headley; L B Elliott
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.